EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Yubo International Biotech's Enterprise Value is $59.06 Mil.
Yubo International Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.74 Mil. Therefore, Yubo International Biotech's EV-to-FCF for today is -79.92.
The historical rank and industry rank for Yubo International Biotech's EV-to-FCF or its related term are showing as below:
YBGJ'
s EV-to-FCF Range Over the Past 10 Years
Min: -4671.1 Med: -53.22 Max: -15.78
Current: -96.18
During the past 4 years, the highest EV-to-FCF of Yubo International Biotech was -15.78. The lowest was -4671.10. And the median was -53.22.
YBGJ's EV-to-FCF is ranked worse than 100% of 362
companies
in the Medical Devices & Instruments industry
Industry Median: 27.625
vs YBGJ: -96.18
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Yubo International Biotech's EV-to-FCF
For the Medical Instruments & Supplies subindustry, Yubo International Biotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yubo International Biotech's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yubo International Biotech's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Yubo International Biotech's EV-to-FCF falls into.
Yubo International Biotech's current Enterprise Value is $59.06 Mil.
Yubo International Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yubo International Biotech (OTCPK:YBGJ) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Yubo International Biotech's PE Ratio for today is calculated as:
Yubo International Biotech's share price for today is $0.72.
Yubo International Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.006.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Yubo International Biotech EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Yubo International Biotech's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Yubo International Biotech (Yubo International Biotech) Business Description
Yubo International Biotech Ltd is a technology company focused on the research and development and application of endometrial stem cells. It offers products and services under the brand VIVCELL. Its product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products. It also offers stem cell-related services including cell testing and health management consulting services. The company derives its revenue from the sale of nebulizers containing frozen tubes with medical fluid and from the sale of oral liquids health products. The nebulizers are sold directly to consumers on its online e-commerce platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
YBGJ has been successfully added to your 